Latest receivables for MNKKQ: $350M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), MNKKQ shows a receivables of $350M. That compares with $400M in the prior-year period — down 12.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MNKKQ's receivables is now $350M (was $400M) — a 12.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Mallinckrodt Plc is outperforming or lagging.
Tracking MNKKQ's receivables over time shows whether Mallinckrodt Plc is scaling, shrinking, or reshaping that part of the business. The current reading is $350M That compares with $400M in the prior-year period — down 12.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Mallinckrodt Plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $350M) with ownership activity and broader fundamentals.
Mallinckrodt Plc's receivables is $350M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.